Prescribing personalized nutrition for cardiovascular health: Are we ready?

Journal of Nutrigenetics and Nutrigenomics

Volumn 7, Issue 3, 2014, Pages 153-160

  Juma, Shanil ^a   Imrhan, Victorine ^a   Vijayagopal, Parakat ^a   Prasad, Chandan ^a  

^a TEXAS WOMAN'S UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Diet; Genes; Nutrition

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN B100; ESTROGEN RECEPTOR ALPHA; GLYCINE HYDROXYMETHYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; INTERLEUKIN 18; LOW DENSITY LIPOPROTEIN RECEPTOR; SUBTILISIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET THERAPY; DIETITIAN; DISORDERS OF LIPID METABOLISM; DNA SEQUENCE; ETHNIC GROUP; FAMILIAL HYPERCHOLESTEROLEMIA; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; HUMAN GENOME; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE; METABOLIC DISORDER; MODIFIER GENE; NUTRIGENOMICS; NUTRITIONAL DEFICIENCY; NUTRITIONAL HEALTH; OBESITY; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SMOKING; SUMOYLATION; UBIQUITINATION; CARDIOVASCULAR DISEASES; CLINICAL PRACTICE; DIET; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; HEALTH CARE POLICY; NUTRITION; PERSONALIZED MEDICINE; TRENDS;

CARDIOVASCULAR DISEASES; DIET; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIVIDUALIZED MEDICINE; NUTRIGENOMICS; NUTRITION POLICY; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84925384988     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000370213     Document Type: Review

References (40)

1. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J: Factors of risk in the development of coronary heart disease-six year follow-up experience: the Framingham Study. Ann Intern Med 1961; 55: 33-50
2. US Department of Health and Human Services: The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014
3. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, et al: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307
4. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, et al: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615-1622
5. Chan L, Boerwinkle E: Gene-environment interactions and gene therapy in atherosclerosis. Cardiol Rev 1994; 2: 130-137
6. Schildkraut JM, Myers RH, Cupples LA, Kiely DK, Kannel WB: Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am J Cardiol 1989; 64: 555-559
7. Colditz GA, Rimm EB, Giovannucci E, Stampfer MJ, Rosner B, et al: A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol 1991; 67: 933-938
8. Hopkins PN, Williams RR, Kuida H, Stults BM, Hunt SC, et al: Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol 1988; 62: 703-707
9. Rissanen A: Familial occurrence of coronary heart disease: effect of age at diagnosis. Am J Cardiol 1979; 44: 60-66
10. Allen G, Harvald B, Shields JP: Measures of twin concordance. Acta Genet Stat Med 1967; 17: 475-481
11. Cooper JA, Miller GJ, Humphries SE: A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis 2005; 181: 93-100
12. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al; International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921
13. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al: The sequence of the human genome. Science 2001; 291: 1304-1350
14. Roberts R, Stewart AFR: Genes and coronary artery disease: where are we? J Am Coll Cardiol 2012; 60: 1715-1721
15. Roberts R, Stewart AFR: Genetics of coronary artery disease in the 21st century. Clin Cardiol 2012; 35: 536-540
16. Ioannidis JPA: Prediction of cardiovascular disease outcomes and established cardiovascular risk factors by genome-wide association markers. Circ Cardiovasc Genet 2009; 2: 7-15
17. Kutz G; United States Government Accountability Office: Nutrigenetic Testing: Tests Purchased from Four Web Sites Mislead Consumers. Washington, US Government Accountability Office, 2006, pp 1-23
18. Blum K, Chen TJH, Williams L, Chen ALC, Downs WB, et al: A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: exploring nutrigenomics. Gene Ther Mol Biol 2008; 12: 371-382
19. Prasad C, Imrhan V, Rew M: Introducing nutritional genomics teaching in undergraduate dietetic curricula. J Nutrigenet Nutrigenomics 2011; 4: 165-172
20. Downing NS, Ross JS: Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe's Personal Genome Service. JAMA 2014; 311: 793-794
21. Ye SQ, Kwiterovich PO Jr: Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol. Am J Clin Nutr 2000; 72: 1275S-1284S
22. Boros LG: Population thiamine status and varying cancer rates between western, Asian and African countries. Anticancer Res 2000; 20: 2245-2248
23. DeBusk RM, Fogarty CP, Ordovas JM, Kornman KS: Nutritional genomics in practice: where do we begin? J Am Diet Assoc 2005; 105: 589-598
24. Carpenter KJ: A short history of nutritional sciences. Part 1 (1785-1885). J Nutr 2003; 133: 638-645
25. Allbaugh LG: Crete: A Case Study of an Underdeveloped Area. Princeton, Princeton University Press, 1953
26. Keys A (ed): Coronary heart disease in seven countries. Circulation 1970; 41(Suppl):1-211
27. Nestle M: Mediterranean diets: historical and research overviews. Am J Clin Nutr 1995; 61: 1313S-1320S
28. Andrade J, Mohamed A, Frohlich J, Ignaszewski A: Ancel Keys and the lipid hypothesis: from early breakthroughs to current management of dyslipidemia. BCMJ 2009; 51: 66-72
29. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, et al: Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129-133
30. Dong C, Yoon W, Goldschmidt-Clermont PJ: DNA methylation and atherosclerosis. J Nutr 2002; 132: 2406S-2409S
31. Yinga AK, Hassanaina HH, Roosa CM, Smiragliab DJ, Issac JPJ, et al: Methylation of the estrogen receptor gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovasc Res 2000; 46: 172-179
32. Risch NJ: Searching for genetic determinants in the new millennium. Nature 2000; 405: 847-856
33. Wernimont SM, Raiszadeh F, Stover PJ, Rimm EB, Hunter DJ, et al: Polymorphisms in serine hydroxymethyltransferase and methylenetetrahydrofolate reductase interact to increase cardiovascular disease risk in humans. J Nutr 2011; 141: 255-260
34. Grisoni ML, Proust C, Alanne M, DeSuremain M, Salomaa V, et al: Haplotypic analysis of tag SNPs of the interleukin-18 gene in relation to cardiovascular disease events: the MORGAM Project. Eur J Hum Genet 2008; 16: 1512-1520
35. Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, et al: Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 1995; 95: 1225-1234
36. Brown MS, Kovanen PT, Goldstein JL: Regulation of plasma cholesterol by lipoprotein receptors. Science 1981; 212: 628-635
37. Tibolla G, Norata GD, Artali R, Meneghetti F, Catapano AL: Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure-function relation to therapeutic inhibition. Nutr Metab Cardiovasc Dis 2011; 21: 835-843
38. Ogawa N, Imai Y, Morita H, Nagai R: Genome-wide association study of coronary artery disease. Int J Hypertens 2010; 2010: 790539
39. Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, et al: The diploid genome sequence of an individual human. PLoS Biol 2007; 5:e254
40. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, et al: The complete genome of an individual by massively parallel DNA sequencing. Nature 2008; 452: 872-876.